Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DYAI
DYAI logo

DYAI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Dyadic International Inc (DYAI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.940
1 Day change
17.79%
52 Week Range
1.450
Analysis Updated At
2026/03/20
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Dyadic International Inc (DYAI) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are mixed, with bearish moving averages and neutral RSI, while the financial performance shows significant revenue decline and weak gross margins. Additionally, there are no positive catalysts or significant trading trends to suggest immediate upside potential. The lack of recent news, congress trading data, and proprietary trading signals further supports a hold recommendation.

Technical Analysis

The MACD is positive and expanding, suggesting mild bullish momentum. However, the RSI is neutral at 52.547, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 0.745, and resistance levels are at 0.836 and 0.865. Overall, the technical outlook is mixed, leaning bearish.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
10

Positive Catalysts

  • NULL identified. There is no recent news, significant trading trends, or congress trading data to act as a positive catalyst.

Neutral/Negative Catalysts

  • Revenue dropped by 40.50% YoY in Q3 2025, and gross margin declined by 84.87%. The stock also lacks recent proprietary trading signals and has bearish moving averages.

Financial Performance

In Q3 2025, revenue dropped to $1,164,617 (-40.50% YoY), while net income improved to -$1,976,012 (+871.20% YoY). EPS increased to -0.06 (+500.00% YoY), but gross margin dropped significantly to 12.07% (-84.87% YoY). Overall, financial performance shows weak revenue growth and profitability concerns.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes are available for DYAI.

Wall Street analysts forecast DYAI stock price to rise
Analyst Rating
0
Wall Street analysts forecast DYAI stock price to rise
Buy
Hold
Sell
0
Current: 0.798
sliders
Low
0
Averages
0
High
0
0
Current: 0.798
sliders
Low
0
Averages
0
High
0
H.C. Wainwright
Swayampakula Ramakanth
NULL -> Buy
initiated
$3
AI Analysis
2025-10-23
Reason
H.C. Wainwright
Swayampakula Ramakanth
Price Target
$3
AI Analysis
2025-10-23
initiated
NULL -> Buy
Reason
H.C. Wainwright analyst Swayampakula Ramakanth assumed coverage of Dyadic International with a Buy rating and $3 price target. The company produces recombinant proteins based on proprietary fungus-based platforms, the analyst tells investors in a research note. The firm is "encouraged" by Dyadic's efforts to expand its platform into further non-pharmaceutical applications and views them as upside to estimates.
Craig-Hallum
Matthew Hewitt
initiated
$5
2025-09-08
Reason
Craig-Hallum
Matthew Hewitt
Price Target
$5
2025-09-08
initiated
Reason
Craig-Hallum analyst Matthew Hewitt initiated coverage of Dyadic International with a Buy rating and $5 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DYAI
Unlock Now

People Also Watch